您的位置: 首页 > 农业专利 > 详情页

Novel 3-hydroxyisothiazole 1-oxide derivative
专利权人:
Ltd.;Mochida Pharmaceutical Co.
发明人:
Ohkouchi, Munetaka
申请号:
AU2012248629
公开号:
AU2012248629A1
申请日:
2012.04.11
申请国别(地区):
AU
年份:
2013
代理人:
摘要:
[Problem] To provide a GPR40 activating agent having as an active ingredient a novel compound having a GPR40 agonist action, a salt thereof, a solvate of the compound or salt, or the like; in particular, an insulin secretagogue or an agent for preventing and/or treating diabetes, obesity, or the like. [Solution] A compound represented by formula (I) [Chemical formula 1] (in the formula, p is 0-4; j is 0-1; k is 0-2; the ring (A) is a heterocyclic group, cycloalkyl group, cycloalkenyl group, spiro ring group, or aryl group optionally substituted at the position (L); the ring (B) is an aryl group or a heteroaryl group; X is O or -NR
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充